
Leucine is transforming pharmaceutical manufacturing with its AI-powered platform that integrates manufacturing, quality, and laboratory operations. The company offers a suite of products designed to streamline workflows, enhance compliance, and improve operational efficiency. With over 300 pharma facilities using its solutions, Leucine is positioned as a leader in the industry, focusing on digital transformation and regulatory adherence to meet the evolving challenges of pharmaceutical production.

Leucine is transforming pharmaceutical manufacturing with its AI-powered platform that integrates manufacturing, quality, and laboratory operations. The company offers a suite of products designed to streamline workflows, enhance compliance, and improve operational efficiency. With over 300 pharma facilities using its solutions, Leucine is positioned as a leader in the industry, focusing on digital transformation and regulatory adherence to meet the evolving challenges of pharmaceutical production.
What they do: AI-powered platform that digitizes and manages shop-floor manufacturing, quality, and laboratory workflows for pharmaceutical companies
Founded: 2019
Market traction: Used by over 300 pharmaceutical facilities
Latest funding: Series A $7.0M (Oct 16, 2023) led by Ecolab
Pharmaceutical manufacturing operations and regulatory compliance (shop-floor digitization, audit readiness, deviation/root-cause identification).
2019
Biotechnology
$7,000,000
Participants reported: Techstars, Axilor Ventures, Pravega Ventures and angel investors
“Series A led by strategic investor Ecolab with participation from Techstars, Axilor Ventures, and Pravega Ventures”